Trears
London, GB · 1 known investors
Find your way into Trears
Trears Biomarkers develops medical devices and biomarker platforms using earwax-based sampling to enable long-term monitoring of chronic conditions like metabolic syndrome and cardiovascular disease. The company operates at the intersection of clinical diagnostics and digital health, serving healthcare systems and clinical partners with non-invasive alternatives to point-in-time blood or saliva testing.
Founders & leadership
DA
Dr Andres Herane-VivesinFounder & CEOAndres Herane-Vives is a psychiatrist who trained at the University of Chile's Psychiatric Clinic and the Clinic Hospital of the University of Barcelona, and completed an MSc in psychiatric research and a PhD on subtypes of depression at King's College London's Institute of Psychiatry, along with a Clinical Development Fellowship in general adult psychiatry at the Maudsley Hospital. His postdoctoral work at University College London examined the use of earwax to measure chronic levels of substances such as cortisol and glucose, and he is founder and CEO of Trears Biomarkers, which develops earwax-based self-sampling devices to diagnose chronic conditions including diabetes, metabolic syndrome, and depression.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- TREARS LTD
- Company number
- 11624582
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 16 Oct 2018
- Registered office
- Flat 16 16 Bramah Road, Brixton, London, SW9 6FJ
- Nature of business (SIC)
- 32500 — Manufacture of medical and dental instruments and supplies72110 — Research and experimental development on biotechnology86220 — Specialists medical practice activities
- Accounts
- last made up to 31 Oct 2025 · next due 31 Jul 2027
- Confirmation statement
- last made up to 20 Jun 2026 · next due 4 Jul 2027
Current officers · 1
- Andrés Herane Vives — director, appointed 16 Oct 2018
Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Trears do?
- Trears Biomarkers develops medical devices and biomarker platforms using earwax-based sampling to enable long-term monitoring of chronic conditions like metabolic syndrome and cardiovascular disease. The company operates at the intersection of clinical diagnostics and digital health, serving healthcare systems and clinical partners with non-invasive alternatives to point-in-time blood or saliva testing.
- Who founded Trears?
- Trears was founded by Dr Andres Herane-Vives.
- Who are Trears's investors?
- Trears's investors include Ganesha Lab.
- Where is Trears headquartered?
- Trears is headquartered in London, GB.